Table 4.
Gene | SNP | Chr | EA | EAF | Internal Replication |
External Replication |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UKB Stage 2
(N = 138,411) |
CHARGE |
SpiroMeta |
Meta-Analysis CHARGE + SpiroMeta | ||||||||||||
β | SE | P Value | N | β | SE | P Value | n | Direction | P Value | P Value | |||||
ACTN3 | rs57127845 | 11 | C | 0.82 | −14.7 | 2.9 | 2.3 × 10−7 | 60,507 | −11.2 | 4.2 | 3.6 × 10−3 | 75,423 | + | 0.473† | 0.014 |
ACTN4 | rs189809900 | 19 | A | 0.98 | −35.8 | 8.9 | 2.8 × 10−5 | 36,112 | 4.7 | 21.3 | 0.414† | 81,081 | — | 0.232 | 0.407 |
CLDN20 | rs34268254 | 6 | TA | 0.39 | 9.0 | 2.3 | 4.6 × 10−5 | 60,507‡ | 7.9‡ | 3.2‡ | 6.4 × 10−3 ‡ | 75,422‡ | +‡ | 0.011‡ | 7.4 × 10−4 * |
GSK3B | rs6805251 | 3 | T | 0.38 | 8.0 | 2.3 | 2.1 × 10−4 | 60,506 | 4.9 | 3.2 | 0.064 | 74,551 | + | 0.083 | 0.033 |
HOXA1 | rs45571645 | 7 | G | 0.98 | 28.7 | 8.3 | 2.9 × 10−4 | 58,929 | 2.3 | 12.0 | 0.425 | 82,863 | — | 0.481† | 0.559 |
HOXB4 | rs201603635 | 17 | T | 0.94 | −16.3 | 4.6 | 1.9 × 10−4 | NA | NA | NA | NA | NA | NA | NA | NA |
ITGB5 | rs17282078 | 3 | T | 0.87 | 15.7 | 3.3 | 9.0 × 10−7 | 60,508 | 13.5 | 4.7 | 2.0 × 10−3 * | 75,422 | + | 0.365 | 6.1 × 10−3 |
KAT8 | rs138259061 | 16 | A | 0.64 | −7.7 | 2.3 | 4.5 × 10−4 | 60,508§ | −6.2 § | 3.3§ | 0.029 § | 82,865 | — | 0.099 | 0.020 |
MMP24 | rs7280 | 20 | A | 0.58 | 9.7 | 2.3 | 9.5 × 10−6 | 60,508 | 8.5 | 3.3 | 5.1 × 10−3 | 81,992 | + | 0.014 | 7.5 × 10−4 * |
NCOR2 | rs72451021 | 12 | ACT | 0.89 | 12.8 | 3.6 | 1.9 × 10−4 | 45,256 | 1.9 | 5.9 | 0.372 | 75,422‖ | +‖ | 0.038 ‖ | 0.074 |
NR3C1 | rs72801051 | 5 | A | 0.84 | 10.7 | 3.0 | 1.6 × 10−4 | 60,507 | 7.5 | 4.4 | 0.046 | 75,421 | + | 0.111 | 0.032 |
ROR2 | rs12684752 | 9 | T | 0.94 | −17.8 | 4.7 | 8.5 × 10−5 | 60,506 | −2.5 | 6.6 | 0.353 | 75,421 | — | 0.398 | 0.415 |
RUNX1 | rs12483501 | 21 | T | 0.63 | 10.1 | 2.5 | 2.1 × 10−5 | 60,508 | 4.0 | 3.9 | 0.150 | 81,992 | + | 0.026 | 0.026 |
SERPINC1 | rs2227603 | 1 | A | 0.97 | −23.1 | 6.6 | 2.5 × 10−4 | 60,508 | −20.6 | 10.0 | 0.020 | 75,423 | — | 0.367 | 0.044 |
SOX9 | rs796209434 | 17 | CT | 0.53 | 7.9 | 2.2 | 2.0 × 10−4 | 60,506¶ | 10.4 ¶ | 3.2¶ | 5.4 × 10−4 * ¶ | 75,422¶ | +¶ | 8.3 × 10−3 ¶ | 6.0 × 10−5 * |
WNT2B | rs351370 | 1 | C | 0.41 | 7.7 | 2.2 | 3.2 × 10−4 | 60,506 | 7.4 | 3.4 | 0.014 | 74,550 | + | 3.2 × 10−3 | 4.9 × 10−4 * |
WNT9A | rs35799012 | 1 | C | 0.83 | −13.5 | 2.9 | 2.2 × 10−6 | 60,508 | −9.4 | 4.7 | 0.024 | 74,552 | — | 2.8 × 10−3 * | 7.1 × 10−4 * |
Definition of abbreviations: CHARGE = Cohorts for Heart and Aging Research in Genomic Epidemiology; Chr = chromosome; EA = effect allele; EAF = EA frequency; NA = not available; UKB = UK Biobank.
Analyses in the whole dataset (N = 346,027). For SpiroMeta, reported only effect direction because β not interpretable (use of rank-based inverse normal transformation). In bold are external replication results with P < 0.05. β values are per-allele effect estimates.
External replication results significant at Bonferroni (P < 3.1 × 10−3).
P value inverted in Fisher’s meta-analysis to reflect the effect in opposite direction (P values reported for UKB stage 2, CHARGE, and SpiroMeta are all one-sided, see text).
Proxy: rs13220615 (r2 = 0.97).
Proxy: rs1978485 (r2 = 0.98).
Proxy: rs11057583 (r2 = 1.0).
Proxy: rs1042678 (r2 = 0.97).